Newomics, Inc.

Newomics, Inc. is a biotechnology company based in Berkeley, California, founded in 2011.

The company focuses on developing innovative platforms for liquid chromatography–mass spectrometry (LC-MS) to enhance precision medicine and personalized healthcare. Newomics specializes in silicon-microfluidic-chip technology, which provides high robustness, sensitivity, specificity, and throughput for analyzing small amounts of biospecimens like blood and urine. The flagship product is the M3 multinozzle emitter, which works with the MnESI ion source to create a plug-and-play platform compatible with various mass spectrometry instruments. Other offerings include the UniESI source, MEA chip, and a microfluidic cell-sorting device called the Senescence Chip. Newomics serves a diverse range of applications, including precision medicine, drug development, clinical diagnostics, and food monitoring, catering to doctors, researchers, and laboratories. The company has received recognition for its technology, including the 2012 R&D 100 Award.